Charles Osborne, MD
Hematology & Oncology Physician · Houston, TX
Charles Osborne, MD is a hematology & oncology physician with a practice address in Houston, Texas, and NPI 1811077225, issued on Oct 17, 2006. Check the license (Texas E9321, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Charles Osborne
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- E9321 TX
Self-reported in NPPES; status is on the state search - Practice location
- 1919 Old Spanish Trl FL 8, Houston, TX 77054
- Phone
- (832) 957-6500
- Enumerated
- Oct 17, 2006
- Record last updated
- Jul 18, 2025
- Medicaid ID
- 103546101 TX
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 922 in Texas → Look up another NPI →
Also registered at 1919 Old Spanish Trl FL 8
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Chey French, MS-PAPhysician Assistant1972301885
- Karla Sepulveda, MDDiagnostic Radiology Physician1871689059
Verify Charles Osborne in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license E9321Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
87% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
110 Medicare Part D claims for 42 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 21% of claims.
Most prescribed
- Letrozole21 claims
- Tamoxifen Citrate19 claims
- Exemestane16 claims
- Verzenio12 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 91.3 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $34.20
1 payment: food and beverage; the largest payer was Puma Biotechnology, Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Charles Osborne among 922 hematology & oncology physician records in Texas
Charles Osborne, MD is one of 922 hematology & oncology physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 7% of them.
- NPI issued2006 · 7% of these records are older, 57% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileNo · 75% of these records are
- Record last updated2025 · 51% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Texas
There are 922 hematology & oncology physician records in Texas.
All 922 in Texas → Every provider in Houston → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Sita Bushan, MDHouston, TX 770541841635620
- Natalie Chen, MD, PHDHouston, TX 770541619474541
- Akiva DiamondHouston, TX 770541770902579
- Ahmed ElkhananyHouston, TX 770541245572510
- Sophia Lee, MDHouston, TX 770541588151401
- Leonido Luznik, M.D.Houston, TX 770541518902261
- Anaum Maqsood, M.D.Houston, TX 770541801203633
- Meera Patel, M.D.Houston, TX 770541891180501
Common questions
What is Charles Osborne, MD's NPI number?
Charles Osborne, MD's National Provider Identifier (NPI) is 1811077225, issued on Oct 17, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Charles Osborne, MD located?
The NPPES record lists a practice address at 1919 Old Spanish Trl FL 8, Houston, TX, 77054. Phone: (832) 957-6500. Providers update this record themselves, so call before visiting.
How can I verify Charles Osborne, MD's license?
NPPES lists Texas license number E9321, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Charles Osborne, MD prescribe under Medicare Part D?
In 2024, Charles Osborne, MD had 110 Medicare Part D claims for 42 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
What is Charles Osborne, MD's MIPS final score?
The 2023 MIPS final score is 91.3 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.